MedTrace Logo

HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia

NCT00777426 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2014-09-26

No results posted yet for this study

Summary

A total of 60 participants will be enrolled. They will be in 3 groups

1. ARV-naïve, HIV-positive ≥ 20 year of age with HAD (n=25) who intend to start ARV
2. ARV-naïve, HIV-positive ≥ 20 year of age without HAD (n=25), who intend to start ARV
3. HIV-negative ≥ 20 year of age (n=10). The protocol team will work with the primary care physician to ensure that the subjects receive standard HIV and ARV care; however, initiation of ARV is not a requirement of the study and ARV will not be provided by the study.

Participant accrual will include 10-15 participants per year. HIV-positive subjects will be tentatively enrolled in HAD vs. non-HAD groups by the enrolling neurologist and subsequently confirmed to that group by a consensus conference held every 6 months by the study neurologists. In cases of disagreement, cases will be re-assigned to the consensus conference determination and recruitment will continue. An external validation consensus conference will be conducted as well every 6-12 months to monitor correct assignment of the level of impairment.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • SEARCH Research Foundation

    lead OTHER

Principal Investigators

  • Jintanat Ananworanich, MD · SEARCH Research Foundation

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2013-06-30
Completion
2013-10-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00777426 on ClinicalTrials.gov